A Study of Pegcetacoplan for Patients With Transplant-associated Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation

NCT05148299 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Transplant-Associated Thrombotic Microangiopathy

Interventions

DRUG: Pegcetacoplan

Sponsor

Swedish Orphan Biovitrum

Collaborators

[object Object]